Register entry
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 20
- Labeller names
- 2
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Tianjin Tianyao Pharmaceuticals Co.,Ltd.Registrant: Tianjin Tianyao Pharmaceuticals Co., Ltd. | No 19 Xinye 9th street, west area of Tianjin Economic-Technological Development Area, Tianjin, China 300462, China (CHN) | Analytical testing, Active ingredient (API) manufacture | 3008256667654534197 |
Catalogue
Drug listings by form and route
2020 active NDC listings: 11 bulk ingredient, 5 human prescription drug, 4 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 8, BULK INGREDIENT 7, ANDA 5.
| Dosage form | NDCs |
|---|---|
| powder | 15 |
| capsule | 4 |
| tablet | 1 |
| Route | NDCs |
|---|---|
| oral | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| tianjin tianyao pharmaceuticals co., ltd. | 16 |
| tianjin tianyao pharmaceuticals co.,ltd. | 4 |
Catalogue
Marketed products
20| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Betamethasone | powder | 57582-007BULK INGREDIENT |
| - | Betamethasone dipropionate | powder | 57582-035DRUG FOR FURTHER PROCESSING |
| - | Celecoxib | powder | 57582-032DRUG FOR FURTHER PROCESSING |
| Celecoxib | Celecoxib | capsule, oral | 57582-211ANDA |
| Celecoxib | Celecoxib | capsule, oral | 57582-212ANDA |
| Celecoxib | Celecoxib | capsule, oral | 57582-213ANDA |
| Celecoxib | Celecoxib | capsule, oral | 57582-214ANDA |
| - | Deflazacort | powder | 57582-040DRUG FOR FURTHER PROCESSING |
| - | Dexamethasone | powder | 57582-031BULK INGREDIENT |
| - | Dexamethasone | powder | 57582-931BULK INGREDIENT |
| - | Dexamethasone Sodium Phosphate | powder | 57582-015BULK INGREDIENT |
| - | Hydrocortisone | powder | 57582-013BULK INGREDIENT |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | tablet, oral | 57582-101ANDA |
| - | Methylprednisolone | powder | 57582-011DRUG FOR FURTHER PROCESSING |
| - | Methylprednisolone hemisuccinate | powder | 57582-012BULK INGREDIENT |
| - | Prednisolone | powder | 57582-004DRUG FOR FURTHER PROCESSING |
| - | Prednisone | powder | 57582-003DRUG FOR FURTHER PROCESSING |
| - | Spironolactone | powder | 57582-030DRUG FOR FURTHER PROCESSING |
| - | Triamcinolone Acetonide | powder | 57582-018BULK INGREDIENT |
| - | Trilostane | powder | 57582-041DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
3- Asymchem IncTianjin, CHN · 4 sites
- Lights Medical Manufacture Co., Ltd.Tianjin, CHN
- Tianjin Kingyork Pharmaceuticals Co., Ltd.Tianjin, CHN
Compare
Comparable companies in China
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Jianerkang Medical Co Ltd1 site · 56 NDC
- Zhejiang Ausun Pharmaceutical Co., Ltd.1 site · 55 NDC
- Hubei Gedian Humanwell Pharmaceutical Co., Ltd1 site · 31 NDC
- Shandong New Time Pharmaceutical Co., Ltd.1 site · 29 NDC
- Anqiu Lu'an Pharmaceutical Co., Ltd.1 site · 27 NDC
- Hainan Poly Pharm. Co., Ltd.1 site · 27 NDC
- Qingdao Qinzeyuan Biotechnology Co Ltd1 site · 27 NDC
- Shenzhen Alvantis Pharma Co., Ltd.1 site · 27 NDC
- El-Peptido (Shanghai) Biopharmaceutical Co., Ltd1 site · 25 NDC
Enquiry
Common questions
- Is Tianjin Tianyao Pharmaceuticals Co., Ltd. FDA approved?
- Tianjin Tianyao Pharmaceuticals Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Tianjin Tianyao Pharmaceuticals Co., Ltd.'s drugs manufactured?
- The FDA register lists Tianjin. Registered operations: analytical testing, active ingredient (API) manufacture.
- What drugs does Tianjin Tianyao Pharmaceuticals Co., Ltd. make?
- 20 products are listed under Tianjin Tianyao Pharmaceuticals Co., Ltd. in the openFDA NDC Directory, most often as powder; capsule; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.